EGFR and lung carcinoma: To verify whether the early emergence of resistant clones could predict the final resistance mechanism in other lung cancer cell models, we investigated a cell line (NCCLu-15) derived from a treatment-naïve 65-years-old female NSCLC patient with EGFR mutation (Figure 5A).